Real-time investigation of human topoisomerase I reaction kinetics using an optical sensor: a fast method for drug screening and determination of active enzyme concentrations.
暂无分享,去创建一个
Y. Ho | B. Knudsen | R. Frøhlich | Oskar Franch | E. L. Kristoffersen | M. Stougaard | M. Etzerodt | Lotte Bjergbæk | Line A. Jørgensen
[1] E. L. Kristoffersen,et al. Molecular Beacon Enables Combination of Highly Processive and Highly Sensitive Rolling Circle Amplification Readouts for Detection of DNA-Modifying Enzymes , 2015 .
[2] J. Lupski,et al. Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. , 2013, Biosensors & bioelectronics.
[3] S. H. Lee,et al. A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer , 2013, Cancer Chemotherapy and Pharmacology.
[4] T. Hsieh,et al. New mechanistic and functional insights into DNA topoisomerases. , 2013, Annual review of biochemistry.
[5] Yi-Ping Ho,et al. DNA-Based Sensor for Real-Time Measurement of the Enzymatic Activity of Human Topoisomerase I , 2013, Sensors.
[6] Baek Kim,et al. Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase. , 2012, Virology.
[7] Cheng-Yang Huang,et al. Characterization of Flavonol Inhibition of DnaB Helicase: Real-Time Monitoring, Structural Modeling, and Proposed Mechanism , 2012, Journal of biomedicine & biotechnology.
[8] Chengxiao Zhang,et al. Sensitive detection of endonuclease activity and inhibition using gold nanorods. , 2012, Biosensors & bioelectronics.
[9] N. Osheroff,et al. DNA cleavage and opening reactions of human topoisomerase IIα are regulated via Mg2+-mediated dynamic bending of gate-DNA , 2012, Proceedings of the National Academy of Sciences.
[10] D. Spiegelman,et al. Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 , 2011, Clinical Cancer Research.
[11] H. Roder,et al. Retroviral Integrases Promote Fraying of Viral DNA Ends* , 2011, The Journal of Biological Chemistry.
[12] A. Bogdanov,et al. Hairpin-like fluorescent probe for imaging of NF-κB transcription factor activity. , 2011, Bioconjugate chemistry.
[13] Ashley H. Hardin,et al. Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification , 2011, Nucleic acids research.
[14] M. Lisby,et al. A Flp-nick system to study repair of a single protein-bound nick in vivo , 2009, Nature Methods.
[15] Felicie F. Andersen,et al. Resolution of Holliday junction substrates by human topoisomerase I. , 2007, Journal of molecular biology.
[16] Y. Pommier,et al. Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.
[17] A. Marangoni. Enzyme Kinetics , 2019, Fundamentals of Biofuels Engineering and Technology.
[18] JAMES C. Wang,et al. Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.
[19] L. Saltz,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.
[20] F. Boege,et al. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis. , 1998, Biochemistry.
[21] W G Hol,et al. A model for the mechanism of human topoisomerase I. , 1998, Science.
[22] M. Eigen,et al. Real-time enzyme kinetics monitored by dual-color fluorescence cross-correlation spectroscopy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Eigen,et al. Rapid assay processing by integration of dual-color fluorescence cross-correlation spectroscopy: high throughput screening for enzyme activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Straub,et al. Separation and functional analysis of eukaryotic DNA topoisomerases by chromatography and electrophoresis. , 1996, Journal of chromatography. B, Biomedical applications.
[25] A. Mildvan,et al. Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. , 1994, Biochemistry.
[26] O. Westergaard,et al. Characterization of intra- and intermolecular DNA ligation mediated by eukaryotic topoisomerase I. Role of bipartite DNA interaction in the ligation process. , 1994, The Journal of biological chemistry.
[27] A. Andersen,et al. Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination. , 1993, The Journal of biological chemistry.
[28] S. Shuman,et al. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. , 1990, The Journal of biological chemistry.
[29] J. Wang,et al. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. , 1989, Cancer research.
[30] L. Liu,et al. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.
[31] J. Wang,et al. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[33] A. Andersen,et al. Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis. , 1985, Nucleic acids research.
[34] Y. Ho,et al. Quantum dot based DNA nanosensors for amplification-free detection of human topoisomerase I , 2014 .
[35] J. Champoux. DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.
[36] R. Ozols. Optimum chemotherapy for ovarian cancer. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[37] A. Fersht. Enzyme structure and mechanism , 1977 .